The role of TP53 pathogenic variants in early-onset HER2-positive breast cancer.
Escudeiro C, Pinto C, Vieira J, Peixoto A, Pinto P, Pinheiro M, Santos C, Guerra J, Lisboa S, Santos R, Silva J, Leal C, Coimbra N, Lopes P, Ferreira M, Sousa AB, Teixeira MR.
Escudeiro C, et al. Among authors: vieira j.
Fam Cancer. 2021 Jul;20(3):173-180. doi: 10.1007/s10689-020-00212-2. Epub 2020 Oct 14.
Fam Cancer. 2021.
PMID: 33051812